Pacifichealth Laboratories Stock Z Score
PHLIDelisted Stock | USD 0.0001 0.00 0.00% |
PacificHealth |
PacificHealth Laboratories Company Z Score Analysis
PacificHealth Laboratories' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current PacificHealth Laboratories Z Score | -11.0 |
Most of PacificHealth Laboratories' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PacificHealth Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionBased on the company's disclosures, PacificHealth Laboratories has a Z Score of -11.0. This is 221.41% lower than that of the Personal Products sector and notably lower than that of the Consumer Staples industry. The z score for all United States stocks is notably higher than that of the company.
PacificHealth Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PacificHealth Laboratories' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PacificHealth Laboratories could also be used in its relative valuation, which is a method of valuing PacificHealth Laboratories by comparing valuation metrics of similar companies.PacificHealth Laboratories is currently under evaluation in z score category among its peers.
PacificHealth Fundamentals
Return On Equity | -0.75 | ||||
Return On Asset | -0.25 | ||||
Profit Margin | (0.14) % | ||||
Operating Margin | (0.14) % | ||||
Current Valuation | 571.89 K | ||||
Shares Outstanding | 20.87 M | ||||
Price To Earning | (0.34) X | ||||
Price To Book | 0.71 X | ||||
Price To Sales | 0.07 X | ||||
Revenue | 6.91 M | ||||
Gross Profit | 2.99 M | ||||
EBITDA | (861.23 K) | ||||
Net Income | (486.31 K) | ||||
Cash And Equivalents | 324.48 K | ||||
Cash Per Share | 0.02 X | ||||
Total Debt | 54.86 K | ||||
Debt To Equity | 0.07 % | ||||
Current Ratio | 1.58 X | ||||
Book Value Per Share | 0.04 X | ||||
Cash Flow From Operations | (503.96 K) | ||||
Earnings Per Share | (0.04) X | ||||
Target Price | 2.8 | ||||
Beta | -275.06 | ||||
Market Capitalization | 87 | ||||
Total Asset | 1.89 M | ||||
Retained Earnings | (20.59 M) | ||||
Working Capital | 676 K | ||||
Current Asset | 1.84 M | ||||
Current Liabilities | 1.17 M | ||||
Z Score | -11.0 | ||||
Net Asset | 1.89 M |
About PacificHealth Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PacificHealth Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PacificHealth Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PacificHealth Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in PacificHealth Pink Sheet
If you are still planning to invest in PacificHealth Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PacificHealth Laboratories' history and understand the potential risks before investing.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Transaction History View history of all your transactions and understand their impact on performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |